Education and Health Notices




NEW ZEALAND GAZETTE, No. 112

18 SEPTEMBER 2014

Education (Early Childhood Centres)

Regulations 1998

Cancellation of Licence for an Early Childhood Centre

Pursuant to Regulation 12(1)(d)(iii) of the Education (Early Childhood Centres) Regulations 1998, and acting under authority delegated by the Secretary for Education,
I hereby cancel the licence dated 5 November 2012, which was granted under those Regulations to Bernadette Eteuati in respect of Loimata Ole Alofa (10091), situated at 299 Kirkbridge Road, Mangere, Auckland.
This notice shall take effect the day after the date of its notification in the New Zealand Gazette.

KARIN DALGLEISH, Senior Manager, ECE Funding and Implementation, Early Learning, Parents and Whānau.

go5736

Education (Early Childhood Services)

Regulations 2008

Cancellation of Licence for an Early Childhood Service

Pursuant to Regulation 32(1)(d)(i) of the Education (Early Childhood Services) Regulations 2008, and acting under authority delegated by the Secretary for Education,
I hereby cancel the licence dated 9 January 2012, which was granted under those Regulations to Beth Newbold in respect of Childcare and Nanny Services (55401), situated at 103–105 Johnsonville Road, Johnsonville, Wellington.
This notice shall take effect the day after the date of its notification in the New Zealand Gazette.

KARIN DALGLEISH, Senior Manager, ECE Funding and Implementation, Early Learning, Parents and Whānau.

go5735

Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Levophed™ 1:1000
Active Ingredient: Noradrenaline acid tartrate monohydrate 2mg/mL equivalent to Noradrenaline base 1mg/mL
Dosage Form: Concentrate for injection
New Zealand Sponsor: Hospira NZ Limited
Manufacturer: Hospira Inc, Kansas, United States of America

Product: Minax XL
Active Ingredient: Metoprolol succinate 23.75mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Laboratories Limited, Maharashtra State, India

Product: Minax XL
Active Ingredient: Metoprolol succinate 47.5mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Laboratories Limited, Maharashtra State, India

Product: Minax XL
Active Ingredient: Metoprolol succinate 95mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Laboratories Limited, Maharashtra State, India

Product: Minax XL
Active Ingredient: Metoprolol succinate 190mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Laboratories Limited, Maharashtra State, India

Product: Sodium Chloride Injection BP 0.9%
Active Ingredient: Sodium chloride 0.9%
Dosage Form: Solution for injection
New Zealand Sponsor: Fresenius Kabi New Zealand Limited
Manufacturer: Fresenius Kabi Espana S.A.U, Barcelona, Spain



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 112





✨ LLM interpretation of page content

🎓 Cancellation of Licence for an Early Childhood Centre

🎓 Education, Culture & Science
Licence cancellation, Early Childhood Centre, Loimata Ole Alofa, Mangere
  • Bernadette Eteuati, Licence holder

  • Karin Dalgleish, Senior Manager, ECE Funding and Implementation, Early Learning, Parents and Whānau

🎓 Cancellation of Licence for an Early Childhood Service

🎓 Education, Culture & Science
Licence cancellation, Early Childhood Service, Childcare and Nanny Services, Johnsonville
  • Beth Newbold, Licence holder

  • Karin Dalgleish, Senior Manager, ECE Funding and Implementation, Early Learning, Parents and Whānau

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
Medicines Act, New medicines, Distribution consent, Levophed, Minax XL, Sodium Chloride Injection